PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacognosy Research Laboratories and Herbal Analysis Services, University of Greenwich, Central Avenue, Chatham-Maritime, UK.\', \'Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran; Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.\', \'Department of Hypertension, Medical University of Lodz, Poland; Polish Mothers Memorial Hospital Research Institute, Lodz, Poland.\', \'Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Functional Genomics and Experimental Pathology, The Oncology Institute \'Prof. Dr. Ion Chiricuta\', Cluj-Napoca, Romania; MEDFUTURE-Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.\', \'Department of Microbiology, St. Xavier\'s College, Kolkata, India.\', \'Department of Molecular Medicine, Bose Institute, Kolkata, India.\', \'Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran; Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: nabavi208@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0188-4409(20)30863-810.1016/j.arcmed.2020.05.024
?:hasPublicationType
?:journal
  • Archives of medical research
is ?:pmid of
?:pmid
?:pmid
  • 32536457
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.009
?:rankingScore_hIndex
  • 68
is ?:relation_isRelatedTo_publication of
?:title
  • Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all